The COVID-19 Pandemic – A Diagnostic Industry Perspective

2Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

The COVID-19 pandemic has brought about unprecedented changes to all facets of the healthcare system, including the diagnostic industry. The pandemic has highlighted both the challenges and strengths of the industry and has also provided valuable insights on how to be better prepared for future pandemics. In this perspective article, we describe the challenges faced by the diagnostic industry in general, particularly the difficulties encountered by Luminex Corporation, a diagnostic assay development and manufacturing company located in Austin, Texas, USA, as well as the mitigation strategies employed. In addition to discussion of the key challenges, the article provides insights on the lessons learned and steps that can be undertaken to better prepare for future outbreaks.

Cite

CITATION STYLE

APA

Das, S., & Dunbar, S. (2022). The COVID-19 Pandemic – A Diagnostic Industry Perspective. Frontiers in Cellular and Infection Microbiology, 12. https://doi.org/10.3389/fcimb.2022.862440

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free